APA (7th ed.) Citation

Li, C., Ko, J., Hsiao, Y., Tsai, M., Lai, Y., Hsin, I., . . . Wu, M. (2021). Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer. Cancer management and research, 13, 9305-9318. https://doi.org/10.2147/CMAR.S338957

Chicago Style (17th ed.) Citation

Li, Che-Hsing, et al. "Plasma Endoglin Is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer." Cancer Management and Research 13 (2021): 9305-9318. https://doi.org/10.2147/CMAR.S338957.

MLA (9th ed.) Citation

Li, Che-Hsing, et al. "Plasma Endoglin Is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer." Cancer Management and Research, vol. 13, 2021, pp. 9305-9318, https://doi.org/10.2147/CMAR.S338957.